ZVRA Q1 2023 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-19.9% YoY

Gross Profit

$3M96.1% margin

Operating Income

-$13M-404.0% margin

Net Income

-$13M-416.2% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+37.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$945,000

Balance Sheet

Total Assets

$107M

Total Liabilities

$35M

Stockholders' Equity

$71M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-19.9%
Gross Profit	$3M	$4M	-22.9%
Operating Income	-$13M	-$2M	-590.2%
Net Income	-$13M	-$2M	-609.1%